PUBLICATION

Lipoprotein lipase regulates hematopoietic stem progenitor cell maintenance through DHA supply

Authors
Liu, C., Han, T., Stachura, D.L., Wang, H., Vaisman, B.L., Kim, J., Klemke, R.L., Remaley, A.T., Rana, T.M., Traver, D., Miller, Y.I.
ID
ZDB-PUB-180405-10
Date
2018
Source
Nature communications   9: 1310 (Journal)
Registered Authors
David, Stachura, Kim, Jungsu, Klemke, Richard, Miller, Yury
Keywords
none
MeSH Terms
  • Animals
  • Apoptosis
  • Azo Compounds/chemistry
  • Cell Separation
  • Docosahexaenoic Acids/metabolism*
  • Female
  • Flow Cytometry
  • Gas Chromatography-Mass Spectrometry
  • Hematopoiesis
  • Humans
  • Hydrolysis
  • In Situ Hybridization
  • Lipoprotein Lipase/genetics
  • Lipoprotein Lipase/metabolism*
  • Lipoproteins, VLDL/metabolism
  • Male
  • Mice
  • Mice, Knockout
  • Mutation
  • Peptides/chemistry
  • Stem Cells/cytology*
  • Triglycerides/chemistry
  • Zebrafish
PubMed
29615667 Full text @ Nat. Commun.
Abstract
Lipoprotein lipase (LPL) mediates hydrolysis of triglycerides (TGs) to supply free fatty acids (FFAs) to tissues. Here, we show that LPL activity is also required for hematopoietic stem progenitor cell (HSPC) maintenance. Knockout of Lpl or its obligatory cofactor Apoc2 results in significantly reduced HSPC expansion during definitive hematopoiesis in zebrafish. A human APOC2 mimetic peptide or the human very low-density lipoprotein, which carries APOC2, rescues the phenotype in apoc2 but not in lpl mutant zebrafish. Creating parabiotic apoc2 and lpl mutant zebrafish rescues the hematopoietic defect in both. Docosahexaenoic acid (DHA) is identified as an important factor in HSPC expansion. FFA-DHA, but not TG-DHA, rescues the HSPC defects in apoc2 and lpl mutant zebrafish. Reduced blood cell counts are also observed in Apoc2 mutant mice at the time of weaning. These results indicate that LPL-mediated release of the essential fatty acid DHA regulates HSPC expansion and definitive hematopoiesis.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping